| HOME >> MEDICINE >> TECHNOLOGY |
630.4563.52,299.31,935.3Earnings from discontinued operations, net of income taxes
—7.292.9237.0Net earnings
$
630.4$
570.7$
2,392.2$
2,172.3Net earnings per share from continuing operations:Basic
$
0.91$
0.82$
3.32$
2.86Diluted
$
0.89$
0.79$
3.23$
2.77Net earnings per share from discontinued operations:Basic
$
0.00$
0.01$
0.13$
0.35Diluted
$
0.00$
0.01$
0.13$
0.34Net earnings per share:Basic
$
0.91$
0.83$
3.45$
3.21Diluted
$
0.89$
0.80$
3.36$
3.11Average common stock and common equivalent shares outstanding:Basic
691.4688.6693.4676.2Diluted
709.6711.4713.1701.2
This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information. DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (unaudited)
($ and shares in millions)As of December 3120122011ASSETSCurrent Assets:Cash and equivalents
$
1,678.7$
537.0Trade accounts receivable, less allowance for doubtful accounts of $121.4 and $117.4,
respectively
3,267.33,049.9Inventories
1,813.41,781.4Prepaid expenses and other current assets
828.4904.1Total current assets
7,587.86,272.4Property, plant and equipment, net
2,140.92,101.0Investment in joint venture
548.3521.9Other assets
858.0739.7Goodwill
15,462.014,474.3Other intangible assets, net
6,344.05,840.2Total assets
$
32,941.0$
29,949.5LIAB
'/>"/>
| SOURCE Danaher Corporation Copyright©2012 PR Newswire. All rights reserved |